Search

Cerus Corp

Open

BrancheGesundheitswesen

2.33 0.87

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

2.11

Max

2.41

Schlüsselkennzahlen

By Trading Economics

Einkommen

-1.3M

-3M

Verkäufe

-2.5M

57M

EPS

-0.01

Gewinnspanne

-5.191

Angestellte

261

EBITDA

-1.5M

-712K

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+90.68% upside

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-138M

478M

Vorheriger Eröffnungskurs

1.46

Vorheriger Schlusskurs

2.33

Cerus Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

2. Nov. 2026, 23:01 UTC

News

Cerus Corporation reported Q3 2026 revenue of $64.0 million, below expectations, while reaffirming full-year guidance of $229 million to $231 million.

30. Okt. 2026, 20:02 UTC

Cerus Corp shares are declining sharply, breaking a trend of higher daily closes observed in recent sessions amid contrasting upward momentum.

22. Okt. 2026, 20:07 UTC

Cerus Corp shares are declining, having peaked early before falling throughout the day, trading well below the 20-day moving average.

21. Okt. 2026, 20:01 UTC

Cerus Corp is trading notably higher, reaching a peak return of over 3% on Wednesday, continuing recent strength above its 20-day moving average.

19. Okt. 2026, 19:26 UTC

Cerus Corp is trading higher, reaching a peak cumulative return in the late morning.

16. Okt. 2026, 23:51 UTC

Cerus Corp shares are declining in after-market trading, falling significantly from an initial uptick and now below the 20-day moving average.

8. Okt. 2026, 20:07 UTC

Cerus Corp shares are declining amid a broader market downturn, pulling back after an earlier session rebound and trading below its 20-day moving average.

5. Okt. 2026, 19:51 UTC

Cerus Corp shares are higher, continuing an upward trend since Friday, supported by positive movement in the broader health care supplies sector.

1. Okt. 2026, 20:02 UTC

Cerus Corp shares fell sharply, reaching their lowest point today and remaining well below the 20-day moving average amid unusually weak performance.

28. Sept. 2026, 19:52 UTC

Cerus Corp shares fell sharply, continuing a significant decline since Friday and reaching their lowest point of the day amid broader market trends.

22. Sept. 2026, 20:01 UTC

Cerus Corp is trading significantly higher, with strong activity and a price above its 20-day moving average, reaching a high cumulative return.

17. Sept. 2026, 20:08 UTC

Cerus Corp is experiencing a sharp increase in its stock price, reaching a notable peak as it rises throughout Thursday's market session.

15. Sept. 2026, 20:07 UTC

Cerus Corp shares are lower amid negative sentiment following a significant decline in the NY Empire State Manufacturing Index, which fell to 7.6 in September.

9. Sept. 2026, 19:46 UTC

Cerus Corp shares are lower during Wednesday's session, continuing a decline since Tuesday's close and remaining near the lower end of their one-month range.

8. Sept. 2026, 21:21 UTC

Cerus Corp shares are higher in after-market trading, rising from a low to a notable high. No specific company news was identified to explain this movement.

2. Sept. 2026, 20:08 UTC

Cerus Corp shares are lower today, extending a decline after five consecutive days of losses. Broader market concerns include slowing private sector employment growth.

31. Aug. 2026, 20:07 UTC

Cerus Corp shares are lower amid broader market concerns over inflation and potential interest rate hikes following the Jackson Hole Economic Symposium.

21. Aug. 2026, 19:26 UTC

Correlated Moves

Cerus Corp shares are higher, supported by gains in the healthcare sector and the ROBO Global Healthcare Technology and Innovation ETF.

20. Aug. 2026, 19:26 UTC

Cerus Corp shares are lower today with no specific news identified. Broader market volatility continues amid rising crude oil prices.

19. Aug. 2026, 19:26 UTC

Correlated Moves

Cerus Corp shares are higher today, supported by a rise in the ARK Genomic Revolution ETF. The stock remains above its 20-day moving average.

18. Aug. 2026, 23:01 UTC

Cerus Corp shares are higher in after-market hours, supported by a significant increase in the Health Care Supplies sub-sector amid overall market gains.

17. Aug. 2026, 19:26 UTC

Cerus Corp shares are lower today, retracing from earlier highs. The stock remains above its 20-day moving average after nine consecutive higher sessions.

14. Aug. 2026, 19:13 UTC

Cerus Corp shares are trading higher during Friday's session, rebounding from an early decline amid notable volatility and increased market volume.

13. Aug. 2026, 19:51 UTC

Macro Event

Cerus Corp is trading higher today, driven by a strong 30-Year Bond Auction yield. The stock has shown notable intraday volatility and high trading volume.

12. Aug. 2026, 20:01 UTC

Cerus Corp shares are higher Wednesday, continuing a seven-session upward trend. Earlier, the stock pulled back from a session high.

11. Aug. 2026, 20:02 UTC

Cerus Corp shares are gaining during Tuesday's session, with unusually high trading volume. No specific news has been identified to explain the movement.

10. Aug. 2026, 20:02 UTC

Cerus Corp shares are higher today, following broader market gains since Friday amid tempered interest rate hike expectations from a recent labor market report.

7. Aug. 2026, 23:56 UTC

Cerus Corp shares are higher in after-market trading, recovering from earlier declines amid shifting expectations for Federal Reserve interest rate hikes.

6. Aug. 2026, 19:46 UTC

Cerus Corp shares are higher in Thursday's session, having gained since Wednesday. The stock remains below its 20-day moving average.

5. Aug. 2026, 19:43 UTC

Cerus Corp shares are higher Wednesday, recovering from an earlier decline amid high trading volume. Broader market sentiment is influenced by ADP's employment report.

Peer-Vergleich

Kursveränderung

Cerus Corp Prognose

Kursziel

By TipRanks

90.68% Vorteil

12-Monats-Prognose

Durchschnitt 4.5 USD  90.68%

Hoch 5 USD

Tief 4 USD

Basierend auf 2 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Cerus Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

2 ratings

2

Buy

0

Halten

0

Sell

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Cerus Corp

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. Cerus Corporation was incorporated in 1991 and is headquartered in Concord, California.
help-icon Live chat